[Selenium and antioxidant status in various diseases].
All healthy mammalian organisms are characterized by an equilibrium between the occurrence of highly reactive oxygen species and their destruction by anti-oxidants. Numerous diseases go hand in hand with a disturbance of the homoeostatis. In order to avoid or minimize the destructive effect of the oxidant stress on biological structures, therapies utilizing drugs with anti-oxidant effects are increasingly being applied. Preconditions for these therapies are a characterisation and a follow-up of the anti-oxidant status in the diseased organism. In the course of the present study selenium, glutathione peroxidase and malondialdehyde were determined in patients with various clinical pictures (terminal renal insufficiency, septic shock, high-risk gravidieties, arterioscleroisis, pulmonary carcinoma, acute myocardial infarction, test patients taking the contraceptive pill). Patients with terminal renal insufficiency and those suffering from septic shock syndromes clearly show a selenium decrease in serum and whole blood as well as a drop in the GSH-Px-activity, and increased malondialdehyde concentrations in the serum. Both are a reflection of an increased lipid peroxidation. First results of a selenium therapy are available for patients with therminal renal insufficiency and post-traumatically induced renal failure. The interpretation of the findings in the categories "high-risk gravidity" and "women on the contraceptive pill", which show a normal GSH-Px-activity and significantly increased malondialdehyde concentrations, seems problematic. The organism counteracts an increased lipid peroxidation with a normal plasma-GSH-Px-activity, clearly a sign of a still normal anti-oxidant potential.
Winnefeld
K
K
Institut für Klinische Chemie und Laboratoriumsdiagnostik, Jena.
Schirrmeister
W
W
Thiele
R
R
Sperschneider
H
H
Klinger
G
G
D058186:Acute Kidney Injury / Q000201:enzymology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001161:Arteriosclerosis / Q000201:enzymology; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005979:Glutathione Peroxidase / Q000097:blood*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000201:enzymology; D008175:Lung Neoplasms / Q000201:enzymology; D008297:Male; D008315:Malondialdehyde / Q000097:blood*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000201:enzymology; D011247:Pregnancy; D018566:Pregnancy, High-Risk / Q000097:blood; D017382:Reactive Oxygen Species / Q000378:metabolism*; D012643:Selenium / Q000008:administration & dosage / Q000097:blood*; D012772:Shock, Septic / Q000201:enzymology
D003276:Contraceptives, Oral; D017382:Reactive Oxygen Species; D008315:Malondialdehyde; D005979:Glutathione Peroxidase; D012643:Selenium
Der Selen- und Antioxidanzienstatus bei verschiedenen Krankheitsbildern.